Newspaper publication of Q2 and H1 FY26-27 financial results

Compliance View source PDF Explain this filing

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.9%Reaction day

₹1914.30

prior close

₹2044.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-1.3% vs market

Specialty Chemicals peers, median of 100sector-3.3%-0.6% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-3.0

15m

-1.8

30m

-3.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.9-2.6-1.3-3.3-0.6

Next day

-14.1-3.6-10.5-4.3-9.7

-18.2-5.8-12.4-6.9-11.3

-18.5-5.5-13.0-6.5-12.0

-16.4pendingpending-5.4-11.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tatva Chintan Pharma Chem informed the exchanges that it has published the extract of financial results for the quarter and half year ended 30 September 2026 in Financial Express (English) and Vadodara Samachar (Gujarati) on 20 October 2026. The disclosure is filed under SEBI Listing Regulations 30 and 47.

Likely market impact

Routine regulatory compliance filing on newspaper publication of results. No direct material impact on the stock price.